Francis RG Amrit BSc (Hons), MSc
Elizabeth K Marsh BSc (Hons)
Molecular Pathobiology
School of Biosciences
University of Birmingham
Introduction
The idea of spending the day looking down a microscope at a culture of worms is something that greatly amuses our friends; little do they know! The organism we are referring to, the nematode Caenorhabditis elegans, which we employ as a model in our laboratory has truly revolutionised biological thinking.
The animal was first adapted as a laboratory model by Sydney Brenner over 40 years ago. He selected this particular soil nematode to be a model system for a number of reasons, which are clear to all C. elegans biologists, indeed the practical advantages of the animals to the laboratory are endless (Brenner, 1974).
Firstly, they have a short generation time of four days and a lifespan of approximately three weeks under laboratory conditions. During this period the animals progress through four larval stages to the 1mm-long adult. This generation time can be regulated by varying the incubation temperature, similar to regulating the reproduction of a bacterial culture! However, there is an alternative to the L3 stage called the dauer stage. Animals enter this state upon crowding or lack of food. Here they are highly resistant to abiotic as well as to pathogenic stress, and they do not age (Riddle et al, 1997).
Figure 1 shows the nematode is transparent and stocks are easy to maintain: animals are cultivated in petri dishes on a modified agar substrate seeded with an Escherichia coli mutant as a food source.
(a)
(b)
Figure 1(a) : A growing C. elegans culture: the population is dominated by self-fertilising hermaphrodites with a rare occurrence of males. 1(b) : A male worm with a distinctive sword shaped tail.
So, why do we study this animal? Well, this simple multicellular organism shares a number of biological features and pathways with higher vertebrates. Stringent studies on this animal therefore point towards key genes and pathways in these higher vertebrates and, having been identified, can be investigated further saving both time and money.
In this way Brenner and his colleagues initially used C. elegans as an organism in which to study animal development and behaviour. During this work, the nervous system was re-constructed, the entire somatic cell lineage was mapped out and the process of programmed cell death was characterised (Riddle et al, 1997). Brenner was co-awarded the Nobel Prize for Medicine in 2002, along with Bob Horvitz and John Sulston, for these studies. The worm has since been awarded a second Nobel Prize in 2006 for the discovery of RNA interference (Fire et al, 1998).
Since then, C. elegans has been used as a model to study a wide-range of biological issues. The organism has been so extensively studied that there is a vast amount of genotypic and phenotypic information available, and the model is genetically tractable. The worm was the first eukaryotic organism to be sequenced (C. elegans Sequencing Consortium, 1998) and this project formed the basis of the human sequencing program which followed shortly afterwards. The wealth of information that is accessible through online resources search as WormBase (http://www.wormbase.org/), has again contributed to the success of C. elegans as a model organism.
In our laboratory we use C. elegans as a whole-organism approach to study the links between gender, immunity and abiotic stress and the subsequent impact these factors have on animal lifespan.
Ageing and Immunity in C. elegans
Ageing which is ironically, an age-old problem in biology is characterised by widespread degenerative changes and an increase in incidence of various age related pathologies or diseases, which include conditions such as cancer, diabetes and stroke. Rather than treating ageing to be an uncontrollable entity, a new wave of research using C. elegans as a model organism has set off trying to understand the mechanics of ageing and to look at it from a different perspective by treating ageing as a problem or a disease.
Calorie restriction was one of the first techniques that employed physiological means to slower the rate of ageing with the first experiments done in the late 1950's where lab mice were successfully made to live for about 40% longer using calorie restriction. But, recently genetic studies in this area have shown that there are molecular mechanisms that are conserved evolutionarily which govern ageing. By intervening with these genetically, it has been shown that the lifespan, immunity and stress resistance (pathogenic invasion, heat etc.) of model organisms like worms (Kenyon et al, 1993), flies (Clancy et al, 2001) and mice (Holzenberger et al, 2003) can be altered and are likely to have a similar effect on vertebrates such as humans. Both these mechanism ultimately result in a better immune and stress response, which also influences lifespan in a positive way.
Single gene mutations that increase lifespan, in some cases doubling it, were first identified in C. elegans in 1993 (Kenyon et al, 1993). Initially the idea of lifespan extension was controversial. It was a radical notion to many scientists who considered ageing as an uncontrolled process of deterioration that isn't controlled by gene regulation. But since the long lived nematode strain was proven to be a result of a mutation in the hormone controlled pathway of molecular signals, there have been over 70 genes identified in the past two decades that lengthen lifespan which is a testament of acceptance and tremendous progress in this field (Johnson, 2003).
Figure 2: A diagram depicting the various possible ways and techniques that can be employed to increase longevity.
The innate immune system which is evolutionarily conserved among all organisms responds immediately upon invasion by pathogens and also contributes towards the initiation of the acquired immune system that is unique to vertebrates. This appears to play the major role in immunity as a whole (Schulenburg et al, 2004). The highly similar features of the innate immune system across organisms suggest that it has a common origin and has been conserved over millions of years' of evolution. Non-vertebrates such as C. elegans can therefore be used to understand the immune system in higher vertebrates (Hasshoff et al, 2007; Schulenburg et al, 2004), which has already been shown by numerous studies on nematode bacterial interaction (Mahajan-Miklos et al, 1999). Molecular studies have helped in the elucidation of hormonal pathways controlling genes involved in antimicrobial actions and stress response that have been documented in C. elegans and these pathways appear to be at work in mammals as well. Mutations in similar hormonal driven pathways have resulted in lifespan extension in other organisms such as fruit flies and mice raising the prospect that this could slow ageing or enable to age with better health in humans too.
There are several known pathways that contribute towards the innate immunity of C. elegans (Garsin et al, 2003; Kim et al, 2002; Mallo et al, 2002; Nicholas and Hodgkin, 2004; Schulenburg et al, 2004). Of these the evolutionarily conserved insulin like/IGF-1 signalling pathway is the most studied with it being shown to regulate several characters such as longevity and metabolism (Paradis and Ruvkun, 1998). This pathway is part of a global endocrine system that is triggered by hormones that resemble the hormone insulin in humans and controls whether animals grow reproductively or arrest at the dauer diapause stage (Finch and Ruvkun, 2001). Single gene mutations in this pathway have been shown to result in a large increase in mean lifespan of about 250 to 300% of the wild type depending on the mutation. The significance of such studies is the possibility to zoom in on a few similar genes as promising targets for drugs in humans that could hence result in a similar outcome.
In 1997 (Kimura et al, 1997) the DNA sequence for the longevity causing mutation (DAF-2) was identified and to everyone's surprise this protein resembled the human cell surface proteins or receptors that respond to insulin and another hormone called insulin like Growth Factor (IGF-1). Also the downstream component DAF-16 (another longevity causing mutation) was identified and it turned out to encode a DNA binding protein that controls expression of its downstream target genes.
In our lab, we study two essential downstream components of the insulin like/IGF-1 signalling pathway, which we propose to be key determinants of immunity, stress resistance and ageing (May, 2007). One of them is the DAF-16 transcription factor which is considered as the "molecular link" that controls the transcription of a whole array of approximately a few hundred downstream genes. In addition we study the antimicrobial lysozyme 7 gene which is one of the many genes transcriptionally controlled by DAF-16.
In nematodes both lifespan and stress resistance have been shown to have gender specific and species specific variability hence suggesting that there is a common molecular mechanism or a "molecular link" which we propose as DAF-16. By establishing this "molecular link" we also plan to address the problem of post reproductive ageing as, if immunity is increased then that would also increase lifespan even after the animal has reproduced which cannot be an evolutionarily selected trait.
Worm research on ageing and immunity has had tremendous success in the recent past with outcomes that have great potential applications in humans. Though there are a lot of questions left to answer, the resounding impact of the IGF-1 signalling pathway research, due to its evolutionary conservation across organisms is reassuring.
References
A. Fire, S.Q.X., M.K. Montgomery, S.A. Kostas, S. E. Driver, C.C. Mello 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:808-811.
Brenner, S. 1974. The Genetics of Caenorhabditis elegans. Genetics. 77.
C. elegans Sequencing Consortium, 1998. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science. 282:2012-2018.
David J. Clancy, D.G., 1* Lawrence G. Harshman,2, H.S. Sean Oldham, 3 Ernst Hafen,3 Sally J. Leevers,4,5, and L. Partridge1. 2001. Extension of Life-Span by Loss of CHICO, a Drosophila Insulin Receptor Substrate Protein. Science. 292,:104.
Donald L. Riddle, T.B., Barbara J. Meyer and James R. Priess 1997. C. elegans II. Cold Spring Harbor Laboratory Press.
Finch, C.E., and G. Ruvkun. 2001. The Genetics of Aging. Annu. Rev. Genomics Hum. Genet. 2:435-462.
Garsin, D.A., J.M. Villanueva, J. Begun, D.H. Kim, C.D. Sifri, S.B. Calderwood, G. Ruvkun, and F.M. Ausubel. 2003. Long-Lived C. elegans daf-2 Mutants Are Resistant to Bacterial Pathogens. Science. 300:1921-.
Hasshoff, M., C. Bohnisch, D. Tonn, B. Hasert, and H. Schulenburg. 2007. The role of Caenorhabditis elegans insulin-like signaling in the behavioral avoidance of pathogenic Bacillus thuringiensis. FASEB J. 21:1801-1812.
Holzenberger, M., J. Dupont, B. Ducos, P. Leneuve, A. Geloen, P.C. Even, P. Cervera, and Y. Le Bouc. 2003. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 421:182-187.
Johnson, T.E. 2003. Advantages and disadvantages of Caenorhabditis elegans for aging research. Experimental Gerontology. 38:1329-1332.
Kenyon, C., J. Chang, E. Gensch, A. Rudner, and R. Tabtiang. 1993. A C. elegans mutant that lives twice as long as wild type. Nature. 366:461-464.
Kim, D.H., R. Feinbaum, G. Alloing, F.E. Emerson, D.A. Garsin, H. Inoue, M. Tanaka-Hino, N. Hisamoto, K. Matsumoto, M.-W. Tan, and F.M. Ausubel. 2002. A Conserved p38 MAP Kinase Pathway in Caenorhabditis elegans Innate Immunity. Science. 297:623-626.
Kimura, K.D., H.A. Tissenbaum, Y. Liu, and G. Ruvkun. 1997. daf-2, an Insulin Receptor-Like Gene That Regulates Longevity and Diapause in Caenorhabditis elegans. Science. 277:942-946.
Mahajan-Miklos, S., M.-W. Tan, L.G. Rahme, and F.M. Ausubel. 1999. Molecular Mechanisms of Bacterial Virulence Elucidated Using a Pseudomonas aeruginosa- Caenorhabditis elegans Pathogenesis Model. Cell. 96:47-56.
Mallo, G.V., C.L. Kurz, C. Couillault, N. Pujol, S. Granjeaud, Y. Kohara, and J.J. Ewbank. 2002. Inducible Antibacterial Defense System in C. elegans. Current Biology. 12:1209-1214.
May, R.C. 2007. Gender, Immunity and the regulation of longevity. Willey Periodicals, BioEssays. 29:795-802.
Nicholas, H.R., and J. Hodgkin. 2004. The ERK MAP Kinase Cascade Mediates Tail Swelling and a Protective Response to Rectal Infection in C. elegans. Current Biology. 14:1256-1261.
Paradis, S., and G. Ruvkun. 1998. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12:2488-2498.
Schulenburg, H., C. Leopold Kurz, and J.J. Ewbank. 2004. Evolution of the innate immune system: the worm perspective. Immunological Reviews. 198:36-58.